ORIGINAL RESEARCH article
Sec. Stem Cell Research
Human mesenchymal amniotic fluid stem cells reveal an unexpected neuronal potential differentiating into functional spinal motor neurons
- 1Department of Medicine and Sciences of Aging, Chieti, Italy
- 2Reprogramming and Cell Differentiation Lab, Center for Advanced Studies and Technology (CAST), Chieti, Italy
- 3Department of Neuroscience, Imaging and Clinical Sciences, Chieti, Italy
- 4Functional Biotechnologies Lab, Center for Advanced Studies and Technology (CAST), University “G. d’Annunzio” of Chieti-Pescara, Chieti, Italy
Human amniotic fluids stem cells (hAFSCs) can be easily isolated from the amniotic fluid during routinely scheduled amniocentesis. Unlike hiPSCs or hESC, they are neither tumorigenic nor immunogenic and their use does not rise ethical or safety issues: for these reasons they may represent a good candidate for the regenerative medicine. hAFSCs are generally considered multipotent and committed towards the mesodermal lineages; however, they express many pluripotent markers and share some epigenetic features with hiPSCs. Hence, we hypothesized that hAFSCs may overcome their mesodermal commitment differentiating into to ectodermal lineages. Here we demonstrated that by the sequential exposure to specific factors, hAFSCs can give rise to spinal motor neurons (MNs), as evidenced by the gradual gene and protein upregulation of early and late MN markers (PAX6, ISL1, HB9, NF-L, vAChT). When co-cultured with myotubes, hAFSCs-derived MNs were able to create functional neuromuscular junctions that induced robust skeletal muscle contractions. These data demonstrated the hAFSCs are not restricted to mesodermal commitment and can generate functional MNs thus outlining an ethically acceptable strategy for the study and treatment of the neurodegenerative diseases.
The irreversible and progressive degeneration of MNs leads to the onset of a group of neurological disorders called motor neuron diseases (MNDs), that cause weakness, progressive paralysis, and death. The survival of patients is about 3 years after the diagnosis and the available pharmacological treatments cannot block the progression of the disease (McDermott and Shaw, 2008; Foster and Salajegheh, 2019). To date the genetic causes and the molecular mechanisms involved in the MNDs onset and progression are still poorly understood; for this reason, the development of in vitro MNDs models is a very important goal, also for testing new and more effective drugs. Nowadays the human (h) MNs are obtained with high efficiency from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs); however, the use of ESCs is forbidden in many countries due to ethical issues, while the generation and the maintenance of hiPSCs require very specialized skills and great costs (Bilic and Belmonte, 2012; Di Baldassarre et al., 2018a).
In the past recent years, the biomedical research has been focused on a new class of stem cells, the perinatal stem cells: these represent a cellular population that can be easily isolated during routine scheduled amniocentesis or from the discarded fetal annexes after delivery without ethical concerns; moreover, they are nor tumorigenic neither immunogenic, and do not rise safety issues (Gaggi et al., 2019; Torre and Flores, 2020). In particular, amniotic fluid includes a heterogeneous cell population, usually derived from the embryo, from which is possible to isolate undifferentiated amniotic fluid stem cells (hAFSCs) by using specific selection process and/or permissive growth conditions. These cells proliferate rapidly and can be kept in culture for many passages without changes in gene and protein expression (Antonucci et al., 2014). hAFSCs are generally considered multipotent and committed towards the mesodermal lineages (Arnhold et al., 2011; Abdulrazzak et al., 2013; Loukogeorgakis and De Coppi, 2017; Di Baldassarre et al., 2018b). However, it has been shown that they express also many pluripotent markers such as NANOG, OCT4, SOX2, REX1 (Antonucci et al., 2014; Gaggi et al., 2019; Gaggi et al., 2020b) and have some epigenetic features similar to the ones of hiPSCs (Gaggi et al., 2020b). Hence, we hypothesised that hAFSCs may overcome the mesodermal commitment differentiating into ectodermal lineages. Aim of this study is to analyse whether hAFSCs can give efficiently rise to a MN progeny.
Materials and methods
Amniotic fluid samples were obtained from healthy women undergoing scheduled amniocentesis for prenatal diagnosis at 16–17 weeks of pregnancy after written informed consent, in accordance with the Declaration of Helsinki. The study was approved by the local ethics committee and all experiments were performed in accordance with relevant guidelines and regulations. To avoid the possible contamination with maternal cells, only normal diploid male karyotypes were included in the study. hAFSCs were isolated as previously described (Di Baldassarre et al., 2018b) Briefly, two or 3 ml of AF were obtained from 3 patients and cells were isolated by centrifugation at 1,200 rpm for 10 min at room temperature (RT). Adherent cells were cultured in Iscove’s modified Dulbecco’s medium (IMDM, Thermo Fisher Scientific, Waltham, MA, United States), supplemented with 20% fetal bovine serum (FBS, Thermo Fisher Scientific, United States), 100 U/mL penicillin/streptomycin, 2 mM L-glutamine, (all from Sigma-Aldrich, Saint Louis, MO, United States), and 5 ng/ml basic fibroblast growth factor (bFGF, Thermo Fisher Scientific, United States), and incubated at 37°C with 5% humidified CO2. The first change of the culture medium was performed after 1 week, and non-adherent cells were removed. Then the medium was changed when the cultures had reached 70%–80% confluence; all the experiments were performed between the 3 and 4 passages.
C2C12 cell line was purchased from ATCC (Mannassan, VA, United States) and cultured in Dulbecco’s Modified Eagle Medium (DMEM, Thermo Fisher Scientific, United States) 10% FBS, supplemented with 1% penicillin/streptomycin and 2 mM L-glutamine. For myotube differentiation, C2C12 at 90% of confluence were cultured in low serum (2% FBS) for 5–6 days.
Phenotypical characterization of hAFSCs was performed between passages 2 and 4, as previously described (Di Baldassarre et al., 2018b). Briefly, cells were treated with the FIX & PERM® Kit (Thermo Fisher Scientific) and then incubated for 1 h at RT with human anti-CD90-Alexa fluor 488-conjugated, CD34-Alexa fluor 488-conjugated, CD45-Alexa fluor 488-conjugated, SSEA4-Alexa fluor conjugated, OCT4-Alexa fluor 488-conjugated, Tra-1–60-Alexa fluor 488-conjugated, C-KIT-PE-conjugated, CD105-FITC-conjugated, NANOG-Alexa fluor 647-conjugated, SOX2-Alexa fluor 488-conjugated (All from Becton Dickinson, Franklin Lakes, NJ, United States) diluted 1:50–1:100 according to the manufacturer’s instructions. Cells incubated with isotypes (all from Becton Dickinson) were used as negative controls. Cytometric analysis was performed with a Cytoflex cytometer (Beckman Coulter Pasadenia, CA, United States), and data were analyzed with CytExpert Acquisition and Analysis Software (Beckman Coulter).
Motor neuron differentiation
For motor neuron differentiation, cells were seeded at high density (5.2 × 104 cell/cm2) on Matrigel (Corning, Flintshire, United Kingdom)-coated plates in IMDM 20% FBS and sequentially exposed to SB431542 hydrate (10 μM, Sigma-Aldrich, United States), LDN193189 (100 nM Stemgent, Cambridge, MA, United States), CHIR-99021 (3 μM, Tocris Bioscience, Bristol, United Kingdom), basic FGF (10 ng/ml Thermo Fisher Scientific, United States), ascorbic acid (10 µM Sigma-Aldrich, United States), RA (100 nM Sigma-Aldrich, United States), Smoothened agonist (SAG) (500 nM, Sigma-Aldrich, United States), DAPT (10 μM, Tocris Bioscience, Bristol, United Kingdom), BDNF (10 ng/ml, R&D system, United States), GDNF (20 ng/ml, R&D system, United States), CTNF (10 ng/mL R&D system, United States) β-mercaptoethanol (βMOH) (25 µM Sigma-Aldrich, United States), Forskolin (10 µM STEMCELL Technologies, Vancouver, British Columbia, Canada), IBMX (100 μM, R&D system, United States).
From day 4, the IMDM medium was gradually replaced with increasing concentrations of N2 medium (IMDM, 1% penicillin/streptomycin, 2 mM L-glutamine, N2 supplement 1:100, B27 w/o vitamin A (B27-) 1:50). At day 11, cells were detached and replated (1.3 × 105cell/cm2) on polyornithine/laminin coated plates in Neurobasal medium (Thermo Fisher Scientific) supplemented with N2, B27 1:50. (Figure 1).
FIGURE 1. Timeline and culture conditions for the MN differentiation of hAFSCs. The picture reported in detail the small molecules used to induce the MN differentiation. Cells were grown on Matrigel until day 11 and then were detached and replated on polyornitine/laminin plates. During the differentiation process the IMDM medium was gradually replaced with N2 medium until day 11, when it was changed into Neurobasal medium supplemented with B27. *IMDM medium: IMDM 20%FBS supplemented 1% penicillin/streptomycin, 2 mM L-glutamine. **N2 medium: IMDM supplemented with N2, 1% penicillin/streptomycin and 2 mM L-glutamine.
Co-cultures of hAFSCs -derived MNs and myotubes
For the co-culture, on day 11 the detached differentiating hAFSCs were seeded on the differentiated C2C12 myotubes (ratio 1:2) in NDM medium supplemented as reported above. When required, hAFSC-derived MNs were loaded with the long-lasting vital dye ViaFluor SE 405 5 µM (Biotium Inc., Fremont, CA, United States) before the plating on the myotubes.
For the non-contacting co-culture, cells were cultured in a µ-slide co-culture dish (Ibidi GmbH, Gräfelfing, Germany).
RNA extraction and reverse transcription
Cells were lysed with QIAzol lysis reagent (QIAGEN, Germany) and the total RNA was extracted using the miRNeasy Mini Kit (QIAGEN, Germany) according to the manufacturer’s procedure. For reverse transcription, 1 μg of RNA was retrotranscribed by the High-Capacity cDNA reverse transcription kit (Thermo Fisher Scientific) according to the manufacturer’s procedure.
Real time quantitative PCR
For all the examined mRNAs, qPCR analysis was performed using SYBR green (PowerUp SYBR Green Master mix, Thermo Fisher Scientific MA United States) as previously described (Gaggi et al., 2020a). The run method consisted of the following steps: 95°C for 10 min, 95°C for 15 s, 60°C for 1 min. Steps 2 and 3 were repeated for 40 cycles. The authenticity of the PCR products was verified by melt-curve analysis. Each gene expression value was normalized to 18S. Since some MN-specific genes were undetectable at day 0, the fold changes were expressed in relation to day 11, as previously reported by Shimojo et al. (Shimojo et al., 2015) using the ΔΔCt method. The primers used are listed in Table 1.
Immunofluorescent analysis was performed as previously described (D’amico et al., 2016; Di Credico et al., 2021a). Briefly, cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.5% Triton X-100 for 15 min and incubated in 5% bovine serum albumin (BSA) for 20 min at room temperature. Cells were subsequently incubated with anti-HB9 Alexa Fluor 488 conjugated 1:50 (Cell Signaling Danvers, MA, United States), anti-NF-L-Alexa Fluor 488 conjugated 1:50 (Cell Signaling Danvers, MA, United States), anti-VaChT 1:100 (Sigma-Aldrich, Saint Louis, MO, United States) followed by the appropriate secondary antibody conjugated with Alexa Alexa Fluor 546 1:100 (Invitrogen, Carlsbad, CA, United States). Nuclei were counterstained with DAPI (Thermo Fisher Scientific, Waltham, MA, United States).
To detect the presence of the neuromuscular junction, hAFSC-derived MNs were stained with the vital staining ViaFluor SE 405 5 µM (Biotium Inc., Fremont, CA, United States), whereas the myotubes were marked with α-bungarotoxin (α-BTX) Alexa Fluor 488 conjugated (Thermo Fisher Scientific, Waltham, MA, United States).
Images were acquired using a confocal system Zeiss LSM800 equipped with an inverted microscope Axio-observer D1 and an objective W-Plan-Apo 40X/1.3 DIC (Carl Zeiss, Jena, Germany). The image analyses were performed by ZEN Software (Carl Zeiss) or Celleste Image Analysis Software (Thermo Fischer Scientific).
The degree of muscle contraction was quantified by the Tracking distance tool of the Celleste Image Analysis Software (Thermo Fisher Scientific): this option allows to automatically select all moving objects contained in the region of interest and tracking their movements over time. The distance covered by each point of the contracting myotubes provides an indirect quantification of the contraction. Numerical data were exported from the data table option and used for statistical analysis. In addition, graphs were obtained to visually represent the myotubes contraction. The distance was expressed as pixel (y-axis) over time (x-axis). The selected regions of interest were maintained constant to permit the comparison among the different experimental conditions. The video were uploaded in the analysis software as MP4 extension.
Intracellular Ca2+ levels were monitored by using the dye Fluo4-acetoxymethyl ester (Fluo4/AM, Thermo Fisher Scientific). An upright microscope (Zeiss Axio Examiner; Carl Zeiss) was used, equipped with 40X 0.75 NA water-immersion objectives connected by optical fiber to a 75 W Xenon lamp and a monochromator (OptoScan; Cairn Instrument, United Kingdom). Sub-millisecond bandpass and wavelength controls were used with a back-illuminated camera (EMCCD, Evolve 512; Photometrics, Tucson, United States). The cells were incubated with 5 µM Fluo-4/AM in normal external solution (NES (in mM: 140 NaCl, 2.8 KCl, 2 CaCl2, 2 MgCl2, 10 glucose, 10 Hepes, pH 7.3) supplemented with 1% (w/v) bovine serum albumin for 40 min at 37°C. Recordings on Fluo4-loaded cells were performed in NES. The fluorescence was acquired by setting excitation at 488 nm and images acquired at 20 frames/s with an EMCCD camera and stored on an interfaced computer for off-line analysis using Metafluor (Molecular Device, Sunnyvale, CA, United States). The temporal analysis was calculated as the mean fluorescence intensity signal in a selected cell area, as F/F0, where F is the fluorescence emission of a single loaded cell acquired during a time lapse, and F0 is the mean fluorescence intensity of the same cell calculated from first images acquired.
All data are presented as the mean ± SD. A statistical analysis was performed using the one-way analysis of variance (ANOVA) and Tukey’s post-hoc analysis. The level of significance was set at p < 0.05.
hAFSCs were characterized by flow cytometry between passages 3 and 4. According to previous data (Di Baldassarre et al., 2018b), they expressed both pluripotent (OCT4, SSEA4, SOX2, NANOG, TRA1-60, C-KIT) and mesenchymal markers CD90 (Table 2).
hAFSC acquire a MN phenotype during the differentiation process
To elucidate whether hAFSCs can be driven towards the MN fate, cell morphology was monitored during the different phases of the differentiation process (Figure 2): undifferentiated cells, characterized by the typical fibroblastic-like morphology, were sequentially exposed to specific molecules to drive the neural induction (Chambers et al., 2009; Chavali et al., 2020; Galiakberova and Dashinimaev, 2020; Gaggi et al., 2021); these MNs progenitors were then detached, replated and treated with specific factors known to promote the MNs differentiation (Maury et al., 2015): immature MNs showed the typical polygonal cell body with few and short dendrites (Day 12). The final maturation was then obtained thanks to the action of neurotrophic factors and was characterized by the increase of dendrites arborization and cell-cell connections (day 22) (Ishii et al., 1993; Hanson et al., 1998; Maury et al., 2015). The morphological analysis was paralleled by the study of expression of genes involved in the spinal MN differentiation; this transcript analysis was performed until day 11, when the cells were replated either on polyornithine/laminin coated plates or on myotubes (Figure 2). Data showed that, as expected, the pluripotency marker OCT4 gradually decreased, whereas PAX6, ISL1 and HB9 that represent early and late MN markers, were upregulated starting rising already after 4 days of the differentiation process.
FIGURE 2. Morphological and gene expression analysis of hAFSC during the differentiation into MNs (A) Schematic representation of key points of MN differentiation. (B) Morphological analysis of different differentiation steps. Magnification 20x, scale bar 50 µm. Pictures are representative of 3 independent experiments. (C) Gene expression of OCT4, PAX6, ISL1 and HB9 was quantified in hAFSCs by qPCR at different time points during the differentiation process, as indicated. The fold changes were expressed in relation to day 11. 18S was used as reference gene. The graphs show the Mean ± SD of 3 independent experiments *p < 0.05.
To confirm the acquisition of the MN phenotype, the expression of proteins involved in the consolidation of MN identity was checked immunocytochemically. As the MN maturation was morphologically evidenced by the increased number, size, and complexity of neurites after 3 weeks of culture, and since stem cells-derived MNs are generally considered mature after 21 days of differentiation (Bianchi et al., 2018), we analyzed the protein expression of the late MN markers HB9, Vesicular acetylcholine transporter (vAChT) and Neurofilament L (NF-L) at day 22. Immunofluorescence revealed that all these markers, undetectable in undifferentiated cells, were strongly and homogeneously expressed by the hAFSC-derived MNs (Figure 3). In particular, NF-L, which is involved in the formation of neuronal cytoskeleton, organized in cytoplasmatic tubular structures, which resembles the intermediate filaments; vAChT, that is a unique marker for cholinergic neurons, evidenced a typical vesicular staining pattern both in the cell body and along the axon; finally, HB9, the spinal MN specific transcription factor, was characterized by a diffuse intracellular distribution both in the nuclei and in the cytoplasm, showing intense fluorescence in the perinuclear region, where the Golgi complex and the endoplasmic reticulum complex are located.
FIGURE 3. Immunofluorescent analysis of late MN markers. Immunostaining and the relative fluorescence intensity for (A) NF-L (green), (B) vAChT (red) and (C) HB9 (green) in undifferentiated cells (day 0) and hAFSC-derived MNs (day 22). The nuclei were counterstained with DAPI. Arrows indicate the cytoskeleton localization of NF-L in (A), the vesicular staining pattern of vAChT in (B) and the HB9 perinuclear localization in (C). Original magnification: 40x, scale bar 20 μm. Red rectangle represents an enlarged area: magnification 60x. Immunofluorescence images are representative of 3 independent experiments.
hAFSC derived MN like cells established a functional neuromuscular junction with myotubes
After the phenotypic characterization, we verified whether after 3 weeks of differentiation, the morphological maturation of the hAFSC-derived MNs was accompanied by the acquisition of some neural functional properties. Using fluorescence video imaging, the cells were stimulated with 50 mM KCl, a depolarizing agent that allows the calcium entry into the cells by the activation of the L-type Ca2+ channels present on the sarcolemma. Data obtained from calcium imaging showed that the differentiated cells did not respond to KCl stimulation, suggesting that after day 22, the hAFSC-derived MN like cells were still functionally immature (Figure 4A).
FIGURE 4. Functional features of hAFSC-derived MNs. (A) Calcium imaging in hAFSC-derived MNs after 22 days of differentiation. Cells were stimulated with 50 mM of KCl. F/F0 represents the ratio of fluorescence intensity for each cell at the indicated time. (B) NMJ detection in the co-culture of hAFSC-derived MNs and myotubes. MNs were labelled with a blue vital staining, whereas the AChRs on myotubes were stained with the α-BTX (green). Red rectangle represents enlarged area (60x). White arrow indicates neuronal terminals ending on the α-BTX (AChRs). Magnification 40x, scale bar 20 µm. The picture is representative of 3 different experiments. (C) Video analysis of the muscle cell contractions in single culture of myotubes, in a contacting co-culture (hAFSC-derived MNs plus myotube) and in a non-contacting co-culture between hAFSC-derived MNs and myotubes. The movements of different points were tracked and quantified by Celleste Image Analysis Software. Graphs are representative of the distance covered by moving points inside three differently ROI.
However, since the functional output of MNs is the muscle cells contraction, the ability of hAFSC-derived-MNs to form neuromuscular junctions (NMJ) with myotubes was checked. For this purpose, after the first 11 days of culture, differentiating hAFSC were detached, loaded with a long-lasting blu vital dye, and then seeded on differentiated C2C12 myotubes. After further 10 days of co-culture, the acetylcholine receptors (AChRs) present on the myotubes were marked with a fluorescent α-bungarotoxin (α-BTX) and the samples analysed. Immunofluorescence evidenced neurites ending on the AChRs of the myotubes (Figure 4B), thus suggesting that hAFSC-derived MNs were competent in developing NMJ. The activity of these NMJ was finally proved by the observation that, while no or very weak contractile activity was observed in C2C12 culture alone, myotubes strongly contract when cultured in presence of hAFSC-derived MNs (Supplementary Videos 1, 2). The degree of the C2C12 myotube contractions was measured by analysing the cell moving on the recorded videos: while in absence of hAFSC-derived MNs only small movements were registered, in the co-culture in which myotubes were in contact with the hAFSC-derived MNs, the cell track evidenced significant shifts of the myotubes at high frequency.
To rule out the possibility that the contractile activity observed in the co-cultures was due to a crosstalk between the cell types via secretory pathways, we set up a non-contacting co-culture, in which hAFSC-derived MNs and C2C12 myotubes grew separately sharing the same media and soluble factors. No contraction movements were observed microscopically in these non-contacting co-culture (Figure 4C).
These results proved that hAFSC-derived MNs can integrate with myotube system creating functional NMJ.
The use of the stem cells is a promising strategy for the treatment of the neurodegenerative disorders, including MNDs. In addition, thanks to their capacity to differentiate into the different neuron types, they may represent a very valuable in vitro model to investigate the molecular bases of NMDs, thus contributing to the development of new and more effective treatments. To date, terminally differentiated MNs can be obtained from hESCs and hiPSCs. The use of these two cellular models ensure high yield of MNs, but it has also some significant disadvantages: hESCs rises important ethical issues, whereas the genetic instability and the epigenetic memory of hiPSCs still cast shadows on their clinical applications (Koch et al., 2009; Mattis and Svendsen, 2011); all these barriers have hampered the use of hESCs and hiPSCs in the medical context.
Perinatal stem cells can be easily obtainable in an inexpensive and non-invasive manner from the amniotic fluid, placenta, and umbilical cord; deriving from fetal annexes, these stem cells lack classical MHC class II antigens and this low immunogenicity give them the potential to escape recognition by alloreactive CD4+ T cells (Gaggi et al., 2019). Mid-trimester human amniotic fluid cells are a heterogeneous population that includes stem cells with intermediate phenotype between the pluripotent and the adult stem cells: indeed, they are characterized by a high proliferation rate, the expression of both pluripotent and mesenchymal markers while maintaining the non-tumor-forming properties of adult cells. All these characteristics encourage the study of their use in regenerative medicine (Gaggi et al., 2020c). As Amniotic Fluids contain a heterogeneous mixture of cell types, the phenotyping of the amniotic cell samples is essential to characterize the starting populations in differentiation experiments. We previously demonstrated that only samples expressing pluripotent and multipotent stem markers such as SSEA4, OCT4 and CD90 may form Embryo Bodies that provide a suitable microenvironment for the differentiation of the residing cells (Antonucci et al., 2014; Di Baldassarre et al., 2018b).
Most of the studies on the differentiation potential of hAFSCs have been carried out by isolating c-Kit+ cells from the initial heterogeneous population. However, data on the surface markers of hAFSCs are not consistent among the different studies and it is still unclear whether sorting for c-Kit expression is necessary or appropriate. Arnhold and coll (Arnhold et al., 2011) evidenced that the c-Kit+ cell fractions preferentially differentiate into mesodermal lineages, while the unsorted population is more prone to the neuronal commitment. This opportunity to develop in vitro neuronal potential without recurring to any immunoselective method is crucial as the absence of xenogenic antibodies is essential in advancing cell therapy applications (Vemuri et al., 2007).
To date, data on the capacity of hAFSCs to differentiate into neurons are often contradictory. Some groups reported that hAFSCs can express the neuron specific class III β-tubulin (Tuji) when stimulated with βMOH and bFGF. Maraldi et al. demonstrated that c-KIT+ hAFSCs expressed neuronal and glial markers, such as Glial fibrillary acidic protein (GFAP), Tuji, Synuclein (SYN) and S-100 when treated with RA (Maraldi et al., 2014). Anyway, no terminal differentiation into a specific class of neurons has been reported yet. Here we reported for the first time that, adapting protocols (Maury et al., 2015; Shimojo et al., 2015; Bianchi et al., 2018) that mimics the different steps of MNs differentiation in vivo, hAFSCs can differentiate into mature MNs. The neural induction was obtained modulating the SHH and the RA signaling, together with Wnt activation: in this phase, the generation of MN progenitors was proved by the expression of Pax6, one of the earliest MN markers. The MN commitment and maturation was then guided by the modulation of the Notch pathway by DAPT, that determines an increased yield of ISL1+ and HB9+ cells (Maury et al., 2015). In vivo, Isl1 and Hb9 are among the first genes expressed in post-mitotic spinal MNs. These two transcription factors play a pivotal role in the consolidation of MN identity, as when their expression is reduced, the developing MNs transdifferentiate into interneurons (Kim et al., 2016), while their ectopic overexpression is sufficient to trigger the MN differentiation (Arber et al., 1999). ISL1 and HB9 continue to be expressed also in mature MNs and they are the most used marker to detect the presence of terminally differentiated MNs (Trawczynski et al., 2019). We found that hAFSC-derived MNs express HB9, whose significant nuclear localization suggests its transcriptional activity, as expected in differentiated cells (Leotta et al., 2014); moreover, HB9 marked also the perinuclear area of the endoplasmic reticulum and the Golgi complex: as these subcellular compartments are closely linked not only by their location in the cytoplasm, but also in their function in the newly synthesized proteins, the HB9 localization in the perinuclear compartment suggests a still active synthesis of the transcription factor in maturing hAFSC-derived MNs. The MNs identity was also supported by the NF-L and vAChT expression: NF-L, that contributes to the structural support for the highly asymmetric geometries of neurons and for the marked radial expansion of the axons (Varhaug et al., 2019), organized relatively sparse and tortuous in dendrites and perikarya forming tubular structures resembling cytoskeleton filaments, while vAChT that provides the storage of acetylcholine into vesicles for its transportation along the neurites (Ferguson et al., 2003; de Castro et al., 2009), localized mainly along the axons and in cell body depicting a typical granular pattern (Ichikawa et al., 1997).
Our data also demonstrated that hAFSC-derived MN can integrate with myotubes forming physiologically relevant connections, as evidenced by the muscular contractile activity observed after about 10 days of co-culture: this timing is the same reported for the NMJ generation from hiPSCs-derived MNs (Puttonen et al., 2015; Yi et al., 2018). We demonstrated immunocytochemically that hAFSC-derived MNs terminate with their axons on the sarcolemma at the AChRs level. It is well known that the AChRs typically gather beneath the motor nerve axon, but in our co-culture system they were more spread along the sarcolemma. This is probably due the immaturity of the C2C12 myotubes: indeed, nicotinic AChRs are initially dispersed throughout the membrane, and only over time they concentrate on the postsynaptic fiber following the neuronal signals (Zhang and Peng, 2011). However, even if the synaptic maturation was not complete, the functionality of the NMJ was proved by the robust contractile activity of the C2C12 myotubes. This observation seems in contrast with analysis of the calcium transients performed on the single cultures of hAFSC-derived MNs after 3 weeks of culture, that evidenced only a slow oscillatory pattern and a non-responsiveness to the depolarizing agent KCl. The discrepancy between this electrophysiological immaturity of hAFSC-derived MNs cultured alone on one hand and the competence to generate functional NMJ on the other can be attributed to the significant contribution of skeletal muscle cells to neuronal physiology: it is well known, indeed, that at the NMJ levels, there is bidirectional crosstalk between MNs and muscle cells. In this scenario, the hypothesis that the myotubes may produce some molecules, such as neurotropic factors, cytokines, exosomes or microparticles (Matthews et al., 2009; Di Credico et al., 2020; Di Credico et al., 2021b; Saini et al., 2021), that might increase the support the maturation of hAFSC-derived MNs cannot be ruled out; however, further investigation on the MNs and myotube secretome, cultured alone or together, are required to specifically address this point.
In conclusions, we demonstrated for the first time that hAFSCs can overcome their mesenchymal restriction and give rise to an ectodermal derivate generating MNs like cells: being easily obtainable and safely transplantable for their low immunogenicity, hAFSCs may represent a promising and useful tool in the study and treatment of the MNDs.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
GG, AC, and SG: investigation and analysis of the data. GG and AC: writing the manuscript draft. AB, BG, and MM supervision and editing.
This work was supported by PRIN Italian Ministry of University and Research (MUR), grant number PRIN 20203AMKTW and ex 60% funds.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2022.936990/full#supplementary-material
Supplementary Video S1 | Myotubes cultured alone
Supplementary Video S2 | Contacting co-culture between hAFSC-derived MN and myotubes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., et al. (2008). Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 26, 1276–1284. doi:10.1038/nbt.1503
Antonucci, I., Di Pietro, R., Alfonsi, M., Centurione, M. A., Centurione, L., Sancilio, S., et al. (2014). Human second trimester amniotic fluid cells are able to create embryoid body-like structures in vitro and to show typical expression profiles of embryonic and primordial germ cells. Cell. Transpl. 23, 1501–1515. doi:10.3727/096368914X678553
Arber, S., Han, B., Mendelsohn, M., Smith, M., Jessell, T. M., Sockanathan, S., et al. (1999). Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 23, 659–674. doi:10.1016/S0896-6273(01)80026-X
Arnhold, S., Glüer, S., Hartmann, K., Raabe, O., Addicks, K., Wenisch, S., et al. (2011). Amniotic-fluid stem cells: growth dynamics and differentiation potential after a CD-117-based selection procedure. Stem Cells Int. 2011, 715341. doi:10.4061/2011/715341
Bianchi, F., Malboubi, M., Li, Y., George, J. H., Jerusalem, A., Szele, F., et al. (2018). Rapid and efficient differentiation of functional motor neurons from human iPSC for neural injury modelling. Stem Cell. Res. 32, 126–134. doi:10.1016/j.scr.2018.09.006
Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M., Sadelain, M., Studer, L., et al. (2009). Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275–280. doi:10.1038/nbt.1529
Chavali, V. R. M., Haider, N., Rathi, S., Vrathasha, V., Alapati, T., He, J., et al. (2020). Dual SMAD inhibition and Wnt inhibition enable efficient and reproducible differentiations of induced pluripotent stem cells into retinal ganglion cells. Sci. Rep. 10, 11828. doi:10.1038/s41598-020-68811-8
D’amico, M. A., Ghinassi, B., Izzicupo, P., Di Ruscio, A., and Di Baldassarre, A. (2016). IL-6 activates PI3K and PKCζ signaling and determines cardiac differentiation in rat embryonic H9c2 cells: IL-6 and cardiac differentiation of H9c2 cells. J. Cell. Physiol. 231, 576–586. doi:10.1002/jcp.25101
de Castro, B. M., De Jaeger, X., Martins-Silva, C., Lima, R. D. F., Amaral, E., Menezes, C., et al. (2009). The vesicular acetylcholine transporter is required for neuromuscular development and function. Mol. Cell. Biol. 29, 5238–5250. doi:10.1128/MCB.00245-09
Di Baldassarre, A., Cimetta, E., Bollini, S., Gaggi, G., and Ghinassi, B. (2018a). Human-induced pluripotent stem cell technology and cardiomyocyte generation: progress and clinical applications. Cells 7, 48. doi:10.3390/cells7060048
Di Baldassarre, A., D’Amico, M. A., Izzicupo, P., Gaggi, G., Guarnieri, S., Mariggiò, M. A., et al. (2018b). Cardiomyocytes derived from human cardiopoieticAmniotic fluids. Sci. Rep. 8, 12028. doi:10.1038/s41598-018-30537-z
Di Credico, A., Gaggi, G., Izzicupo, P., Bucci, I., and Di Baldassarre, A. (2021a). Resveratrol enhances the cytotoxic activity of lymphocytes from menopausal women. Antioxidants 10, 1914. doi:10.3390/antiox10121914
Di Credico, A., Gaggi, G., Izzicupo, P., Ferri, L., Bonanni, L., Iannetti, G., et al. (2021b). Real-time monitoring of levetiracetam effect on the electrophysiology of an heterogenous human iPSC-derived neuronal cell culture using microelectrode array technology. Biosensors 11, 450. doi:10.3390/bios11110450
Di Credico, A., Izzicupo, P., Gaggi, G., Di Baldassarre, A., and Ghinassi, B. (2020). Effect of physical exercise on the release of microparticles with angiogenic potential. Appl. Sci. (Basel). 10, 4871. doi:10.3390/app10144871
Ferguson, S. M., Savchenko, V., Apparsundaram, S., Zwick, M., Wright, J., Heilman, C. J., et al. (2003). Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J. Neurosci. 23, 9697–9709. doi:10.1523/JNEUROSCI.23-30-09697.2003
Gaggi, G., Di Credico, A., Izzicupo, P., Alviano, F., Di Mauro, M., Di Baldassarre, A., et al. (2020a). Human mesenchymal stromal cells unveil an unexpected differentiation potential toward the dopaminergic neuronal lineage. Int. J. Mol. Sci. 21, 6589. doi:10.3390/ijms21186589
Gaggi, G., Di Credico, A., Izzicupo, P., Antonucci, I., Crescioli, C., Di Giacomo, V., et al. (2020b). Epigenetic features of human perinatal stem cells redefine their stemness potential. Cells 9, 1304. doi:10.3390/cells9051304
Gaggi, G., Di Credico, A., Izzicupo, P., Iannetti, G., Di Baldassarre, A., Ghinassi, B., et al. (2021). Chemical and biological molecules involved in differentiation, maturation, and survival of dopaminergic neurons in health and Parkinson’s disease: physiological aspects and clinical implications. Biomedicines 9, 754. doi:10.3390/biomedicines9070754
Gaggi, G., Di Credico, A., Izzicupo, P., Sancilio, S., Di Mauro, M., Iannetti, G., et al. (2020c). Decellularized extracellular matrices and cardiac differentiation: study on human amniotic fluid-stem cells. Int. J. Mol. Sci. 21, 6317. doi:10.3390/ijms21176317
Gaggi, G., Izzicupo, P., Di Credico, A., Sancilio, S., Di Baldassarre, A., Ghinassi, B., et al. (2019). Spare parts from discarded materials: fetal annexes in regenerative medicine. Int. J. Mol. Sci. 20, 1573. doi:10.3390/ijms20071573
Galiakberova, A. A., and Dashinimaev, E. B. (2020). Neural stem cells and methods for their generation from induced pluripotent stem cells in vitro. Front. Cell. Dev. Biol. 8, 815. doi:10.3389/fcell.2020.00815
Hanson, M. G., Shen, S., Wiemelt, A. P., McMorris, F. A., and Barres, B. A. (1998). Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J. Neurosci. 18, 7361–7371. doi:10.1523/JNEUROSCI.18-18-07361.1998
Ichikawa, T., Ajiki, K., Matsuura, J., and Misawa, H. (1997). Localization of two cholinergic markers, choline acetyltransferase and vesicular acetylcholine transporter in the central nervous system of the rat: in situ hybridization histochemistry and immunohistochemistry. J. Chem. Neuroanat. 13, 23–39. doi:10.1016/S0891-0618(97)00021-5
Ishii, K., Katayama, M., Hori, K., Yodoi, J., and Nakanishi, T. (1993). Effects of 2-mercaptoethanol on survival and differentiation of fetal mouse brain neurons cultured in vitro. Neurosci. Lett. 163, 159–162. doi:10.1016/0304-3940(93)90371-Q
Kim, K.-T., Kim, N., Kim, H.-K., Lee, H., Gruner, H. N., Gergics, P., et al. (2016). ISL1-based LIM complexes control Slit2 transcription in developing cranial motor neurons. Sci. Rep. 6, 36491. doi:10.1038/srep36491
Koch, P., Kokaia, Z., Lindvall, O., and Brüstle, O. (2009). Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling. Lancet. Neurol. 8, 819–829. doi:10.1016/S1474-4422(09)70202-9
Leotta, C. G., Federico, C., Brundo, M. V., Tosi, S., and Saccone, S. (2014). HLXB9 gene expression, and nuclear location during in vitro neuronal differentiation in the SK-N-be neuroblastoma cell line. PLoS ONE 9, e105481. doi:10.1371/journal.pone.0105481
Loukogeorgakis, S. P., and De Coppi, P. (2017). Concise review: amniotic fluid stem cells: the known, the unknown, and potential regenerative medicine applications. STEM CELLS 35, 1663–1673. doi:10.1002/stem.2553
Maraldi, T., Bertoni, L., Riccio, M., Zavatti, M., Carnevale, G., Resca, E., et al. (2014). Human amniotic fluid stem cells: neural differentiation in vitro and in vivo. Cell. Tissue Res. 357, 1–13. doi:10.1007/s00441-014-1840-x
Matthews, V. B., Åström, M.-B., Chan, M. H. S., Bruce, C. R., Krabbe, K. S., Prelovsek, O., et al. (2009). Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase. Diabetologia 52, 1409–1418. doi:10.1007/s00125-009-1364-1
Maury, Y., Côme, J., Piskorowski, R. A., Salah-Mohellibi, N., Chevaleyre, V., Peschanski, M., et al. (2015). Combinatorial analysis of developmental cues efficiently converts human pluripotent stem cells into multiple neuronal subtypes. Nat. Biotechnol. 33, 89–96. doi:10.1038/nbt.3049
Puttonen, K. A., Ruponen, M., Naumenko, N., Hovatta, O. H., Tavi, P., Koistinaho, J., et al. (2015). Generation of functional neuromuscular junctions from human pluripotent stem cell lines. Front. Cell. Neurosci. 9, 473. doi:10.3389/fncel.2015.00473
Rubino, E., Cruciani, M., Tchitchek, N., Le Tortorec, A., Rolland, A. D., Veli, Ö., et al. (2021). Human ubiquitin-specific peptidase 18 is regulated by microRNAs via the 3’Untranslated region, a sequence duplicated in long intergenic non-coding RNA genes residing in chr22q11.21. Front. Genet. 11, 627007. doi:10.3389/fgene.2020.627007
Saini, J., Faroni, A., Reid, A. J., Mouly, V., Butler‐Browne, G., Lightfoot, A. P., et al. (2021). Cross-talk between motor neurons and myotubes via endogenously secreted neural and muscular growth factors. Physiol. Rep. 9, e14791. doi:10.14814/phy2.14791
Shimojo, D., Onodera, K., Doi-Torii, Y., Ishihara, Y., Hattori, C., Miwa, Y., et al. (2015). Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells. Mol. Brain 8, 79. doi:10.1186/s13041-015-0172-4
Trawczynski, M., Liu, G., David, B. T., and Fessler, R. G. (2019). Restoring motor neurons in spinal cord injury with induced pluripotent stem cells. Front. Cell. Neurosci. 13, 369. doi:10.3389/fncel.2019.00369
Vemuri, M. C., Schimmel, T., Colls, P., Munne, S., and Cohen, J. (2007). “Derivation of human embryonic stem cells in xeno-free conditions,” in Stem cell assays methods in molecular Biology. Editor M. C. Vemuri (Totowa, NJ: Humana Press), 1–10. doi:10.1007/978-1-59745-536-7_1
Yi, H., Xie, B., Liu, B., Wang, X., Xu, L., Liu, J., et al. (2018). Derivation and identification of motor neurons from human urine-derived induced pluripotent stem cells. Stem Cells Int., 3628578. doi:10.1155/2018/3628578
Yu, C.-H., Davidson, S., Harapas, C. R., Hilton, J. B., Mlodzianoski, M. J., Laohamonthonkul, P., et al. (2020). TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell. 183, 636–649. e18. doi:10.1016/j.cell.2020.09.020
Keywords: amniotic fluid stem cells (AFSC), mesenchimal cells, motoneuron (MN), regenerative medicine, perinatal stem cells
Citation: Gaggi G, Di Credico A, Guarnieri S, Mariggiò MA, Di Baldassarre A and Ghinassi B (2022) Human mesenchymal amniotic fluid stem cells reveal an unexpected neuronal potential differentiating into functional spinal motor neurons. Front. Cell Dev. Biol. 10:936990. doi: 10.3389/fcell.2022.936990
Received: 05 May 2022; Accepted: 04 July 2022;
Published: 22 July 2022.
Edited by:Darius Widera, University of Reading, United Kingdom
Reviewed by:Elisa Cimetta, University of Padua, Italy
Xuegang Yuan, University of California, Los Angeles, United States
Copyright © 2022 Gaggi, Di Credico, Guarnieri, Mariggiò, Di Baldassarre and Ghinassi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Angela Di Baldassarre, email@example.com
†These authors have contributed equally to this work